GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OTCPK:CLVSF) » Definitions » Valuation Rank

CLVSF (CellaVision AB) Valuation Rank


View and export this data going back to 2010. Start your Free Trial

What is CellaVision AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

CellaVision AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

CellaVision AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OTCPK:CLVSF) » Definitions » Valuation Rank
Comparable Companies
OSTO:BACTI B OSTO:BICO OSTO:MCAP OSTO:SEDANA OSTO:CRAD B OSTO:SEZI OSTO:BRAIN OSTO:MNTC OSTO:PRO OSTO:INTEG B ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
CEVI:Sweden 0MR5:UK C26:Germany
Address
Mobilvagen 12, Lund, SWE, 22362
Website
https://www.cellavision.com
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers/software.